Boston Scientific Corporation
45.69USD
-0.3200 (-0.70%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on BSX.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.72▼ | $0.84 | 0 | 11 |
| Next quarter | $0.83▼ | $0.89 | 1 | 5 |
| Current year | $3.23▼ | $3.36 | 0 | 11 |
| Next year | $3.38▼ | $3.71 | 0 | 11 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.83 | $0.86 | +0.03 (+3.9%) |
| 2026-03-31 | $0.79 | $0.8 | +0.01 (+1.6%) |
| 2025-12-31 | $0.78 | $0.8 | +0.02 (+2.4%) |
| 2025-09-30 | $0.71 | $0.75 | +0.04 (+5.1%) |
460 ratings from 45 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Buy | $57 $51 | Oct 14, 2026 |
| Barclays | Initiated | Equal-Weight | $48 | Oct 7, 2026 |
| Citigroup | Maintained | Neutral | $50 $48 | Oct 5, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $50 $48 | Sep 24, 2026 |
| Oppenheimer | Maintained | Outperform | $85 $65 | Sep 21, 2026 |
| Citigroup | Downgraded from Buy | Neutral | $57 $50 | Sep 17, 2026 |
| BTIG | Maintained | Buy | $60 $56 | Sep 9, 2026 |
| TD Cowen | Reiterated | Buy | $56 | Aug 25, 2026 |
| Argus Research | Downgraded from Buy | Hold | — | Jul 31, 2026 |
| UBS | Maintained | Buy | $74 $67 | Jul 30, 2026 |
| Citigroup | Maintained | Buy | $70 $61 | Jul 30, 2026 |
| RBC Capital | Maintained | Outperform | $85 $70 | Jul 30, 2026 |
| TD Cowen | Maintained | Buy | $61 $56 | Jul 30, 2026 |
| Canaccord Genuity | Maintained | Buy | $70 $66 | Jul 30, 2026 |
| Truist Securities | Maintained | Buy | $62 $57 | Jul 30, 2026 |
| Evercore ISI Group | Maintained | Outperform | $65 $55 | Jul 30, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $55 $50 | Jul 30, 2026 |
| BTIG | Maintained | Buy | $65 $60 | Jul 29, 2026 |
| Oppenheimer | Maintained | Outperform | $90 $85 | Jul 27, 2026 |
| Truist Securities | Maintained | Buy | $64 $62 | Jul 16, 2026 |
| Mizuho | Maintained | Outperform | $90 $70 | Jul 15, 2026 |
| RBC Capital | Maintained | Outperform | $100 $85 | Jul 13, 2026 |
| Needham | Maintained | Buy | $77 $57 | Jul 8, 2026 |
| Evercore ISI Group | Maintained | Outperform | $78 $65 | Jul 6, 2026 |
| Stifel | Maintained | Buy | $75 $65 | Jun 25, 2026 |
155 filings from 22 insiders · 0 buy / 0 sell over 6m
Officers and directors of BSX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| O'Connor Padraig AndrewOfficer, EVP, Global Operations | ExerciseRestricted Stock Units | 1.2k | — | — | Sep 2, 2026 |
| O'Connor Padraig AndrewOfficer, EVP, Global Operations | Tax | 567 | $48.37 | $27k | Sep 2, 2026 |
| O'Connor Padraig AndrewOfficer, EVP, Global Operations | Exercise | 1.2k | — | — | Sep 2, 2026 |
| MORANO SUSAN E.Director | Buy | 2.0k | $49.22 | $100k | Aug 25, 2026 |
| HABIGER DAVID CDirector | Buy | 2.1k | $47.59 | $100k | Aug 5, 2026 |
| HABIGER DAVID CDirector | Buy | 1.2k | $48.07 | $57k | Aug 4, 2026 |
| MAHONEY MICHAEL FChief Executive Officer | Buy | 186.2k | $48.33 | $9.00M | Aug 3, 2026 |
| LUDWIG EDWARD J.Director | Buy | 5.0k | $45.48 | $227k | Jul 31, 2026 |
| MONSON JONATHAN RChief Financial Officer | Other | 2.1k | — | — | Jul 1, 2026 |
| MAHONEY MICHAEL FChief Executive Officer | Giftindirect | 386.8k | — | — | May 28, 2026 |
| LUDWIG EDWARD J.Director | Buy | 3.6k | $56.68 | $203k | May 20, 2026 |
| PEGUS CHERYLDirector | Buy | 1.8k | $56.49 | $100k | May 20, 2026 |
| HABIGER DAVID CDirector | Buy | 4.5k | $55.92 | $251k | May 20, 2026 |
| MEGA JESSICA L M.D.Director | Grant | 3.8k | — | — | May 7, 2026 |
| MORANO SUSAN E.Director | Grant | 5.1k | — | — | May 7, 2026 |
| WEBER CHRISTOPHE PIERREDirector | Grant | 2.9k | — | — | May 7, 2026 |
| LUDWIG EDWARD J.Director | Grant | 3.8k | — | — | May 7, 2026 |
| ZANE ELLEN MDirector | Grant | 3.8k | — | — | May 7, 2026 |
| WICHMANN DAVID SDirector | Grant | 3.8k | — | — | May 7, 2026 |
| HABIGER DAVID CDirector | Grant | 3.8k | — | — | May 7, 2026 |
Analyst Ratings
28 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 6 | 18 | 6 | 0 | 0 | Buy2.00 |
| 1 mo ago | 8 | 17 | 6 | 0 | 0 | Buy1.94 |
| 2 mo ago | 8 | 18 | 5 | 0 | 0 | Buy1.90 |
| 3 mo ago | 8 | 18 | 5 | 0 | 0 | Buy1.90 |
Members whose judged calls on BSX have played out most reliably.
No settled calls on BSX yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice